94. 原発性硬化性胆管炎 Primary sclerosing cholangitis Clinical trials / Disease details


臨床試験数 : 142 薬物数 : 115 - (DrugBank : 37) / 標的遺伝子数 : 19 - 標的パスウェイ数 : 139

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00955149
(ClinicalTrials.gov)
August 20095/8/2009Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC)An Open Label Pilot Trial of Erlotinib (Tarceva) in Primary Sclerosing Cholangitis With Trisomy 7Primary Sclerosing Cholangitis;Trisomy 7;Cholangiocarcinoma;ChemopreventionDrug: Erlotinib (Tarceva)Mayo ClinicGenentech, Inc.Completed18 YearsN/ABoth6Phase 1United States